Designing a Smoke-Free Future

Similar documents
Investor Day Lausanne, September 29, Nicholas Rolli Vice President, Investor Relations & Financial Communications

Investor Day Lausanne, September 27, 2018

Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free

Morgan Stanley Global Consumer & Retail Conference New York, November 19, 2014

JT Group Consolidated Financial Results 2018 First Quarter Results

Investor Day LA&C Region Lausanne, September 29, Jeanne Pollès President, Latin America & Canada Region

Slide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes

Investor Day Lausanne, June 21, André Calantzopoulos Chief Operating Officer Philip Morris International

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

Investor Day EU Region Lausanne, June 26, Drago Azinovic President, European Union Region Philip Morris International

Vontobel Viewpoints FDA New Direction on Tobacco Our Take

Genomic Health. Kim Popovits, Chairman, CEO and President

Investor Day Lausanne, September 27, 2018

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 27, 2018

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics

Global EHS Resource Center

Tobacco Insights May

AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes

34 th Annual J.P. Morgan Healthcare Conference

Reduced-Risk Products Science Update

Slide 1. Investor presentation. London 5 February 2019

International Operations overview and strategy. Maziar Mike Doustdar EVP International Operations. Slide 1

ASCO 2018 investor event; breakout 2: Lynparza lifecycle; MRK collaboration

Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America

Patrick J. Sullivan Chief Executive Officer. January 9, 2018 Investor Presentation

USPSTF Draft Recommendations Investor Call. October 6, 2015

Merck Announces FDA Approval of KEYTRUDA. Provided to Investors as a Reference

Industry Post-Regulation. E-Cigarette Summit Tim Phillips, ECigIntelligence. 17 th November

Prohibition of importation, manufacturing and sale of Smokeless Tobacco products.

January 30, 2018 Dow Wilson President and Chief Executive Officer

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

Slide 1. Welcome and introduction. Lars Rebien Sørensen President & CEO

Michael L. Levitz Chief Financial Officer. November 15, 2017 Investor Presentation

For personal use only

Q Investor Kit JANUARY-JUNE 2013

Slide 1. Welcome and strategy update. Lars Fruergaard Jørgensen President and CEO

22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors

Asia Illicit Tobacco Indicator 2016: Philippines. Prepared by Oxford Economics October 2017

Philip Morris International (PMI)

Oral semaglutide and production expansion. Henrik Wulff EVP Product Supply. Peter Kristensen SVP Global Development

Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015

A GLOBAL LEADER IN PERSONALIZED NUTRITION

RAI: Strong key-brands performance delivers 2Q13 profit growth; Company reaffirms full-year EPS guidance

The Cigarette Market in Netherlands

Endesa 1Q 2017 Results 09/05/2017

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

Remarks by André Calantzopoulos Chief Executive Officer. Jacek Olczak Chief Operating Officer. Martin King Chief Financial Officer

RAI reports strong 2Q16 performance and positive outlook; Accelerates returns to shareholders

The importance of offering adult smokers a portfolio of potentially less harmful products

REPORT FROM THE COMMISSION TO THE COUNCIL. on Directive 2011/64/EU on the structure and rates of excise duty applied to manufactured tobacco

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

Investor Day Reduced-Risk Products Lausanne, September 29, 2016

DELICA D:5 ACTIVE GEAR 0

Media Contact: Ron Rogers Investor Contact: Scott Gleason (801) (801)

Q Investor Kit JANUARY-JUNE 2014

Why has the Commission presented these fundamental proposals for change to the system of excise duty on tobacco?

Canadian Experience in Tobacco Regulations. NCDs Expert Meeting Washington, DC November 17, 2014

Argos Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results

January 2017 Investor Presentation. confidently live life with ease

27 th Annual J.P. Morgan Healthcare Conference. January 13, 2009

2014 CAGNY Investor Presentation. February 19, 2014

Our Focus on Driving Shareholder Value Begins Here

Presentation to 2019 JP Morgan Healthcare Conference

H. LUNDBECK A/S. Teleconference. 10 August PM CET. Financial results Second quarter 2011

CYCLOTRONS WORLD MARKET REPORT & DIRECTORY EDITION TOC and Summary USED IN NUCLEAR MEDICINE MARKET DATA, COMPANIES PROFILES.

Raising Tobacco Taxes A Summary of Evidence from the NCI-WHO Monograph on the Economics of Tobacco and Tobacco Control

Asia Illicit Tobacco Indicator 2016: Singapore. Prepared by Oxford Economics October 2017

DARA Reports Year-End 2012 Financial Results

TELECONFERENCE FY February 2015

Asia Illicit Tobacco Indicator 2016: Pakistan. Prepared by Oxford Economics November 2017

Slide 1. Winning with GLP-1. Lars Fruergaard Jørgensen President and CEO. ALEXANDRE DE GREGORIO, Brazil Alexandre has type 2 diabetes

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

The Economics of Tobacco Control and Tobacco Taxation: Challenges & Opportunities for a Tobacco Free Turkey

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO

Remarks by. Manuel Peitsch Chief Scientific Officer, Reduced-Risk Products. Mirek Zielinski President, Reduced-Risk Products

Tamsulosin Hydrochloride 0.4 mg Capsule

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

RAI increases 3Q13 earnings on strong operating performance; tightens full-year EPS guidance

Walgreens (WAG) Analyst: Juan Fabres Fall 2014

Diagnostics for the early detection and prevention of colon cancer. Fourth-Quarter 2014 Earnings Call February 24, 2015

Q Investor Kit JANUARY-MARCH 2014

Strengthening our global leadership in treatment of addiction. Morgan Stanley Global Healthcare Conference September 13 th and 14 th 2018

GROWTH NOW! Franck Riboud

OBALON THERAPEUTICS, INC. (OBLN) The first and only FDA-approved swallowable, gas-filled intragastric balloon for weight loss

How to Regulate E-Cigarettes? Are we asking the right questions?

Clovis Oncology Announces Q Operating Results and Corporate Update. November 3, :05 PM ET

The acquisition of Fortitech

Hot Topics In Preparedness. Lessons Learned in Business Continuity

TFI WHO 20 Avenue Appia 1211 Geneva 27, Switzerland. Gentlemen:

The Global Tobacco Problem

Q Investor Kit JANUARY-MARCH 2013

2013 H1/Q2 Financial Results AIM: GWP NASDAQ: GWPH

The Cigarette Market in Belarus

Ayda A. Yurekli Coordinator, Tobacco Control Economics Tobacco Free Initiative WHO

Sarajevo Halal Fair (SHF) 2018

Category ADVICE. For Tobacconists Only.

For personal use only

Transcription:

Designing a Smoke-Free Future Morgan Stanley Global Consumer & Retail Conference New York, November 14, 2017 Jacek Olczak Chief Financial Officer Martin King President, Asia Region

Forward-Looking and Cautionary Statements This presentation and related discussion contain projections of future results and other forward-looking statements. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products; health concerns relating to the use of tobacco products and exposure to environmental tobacco smoke; litigation related to tobacco use; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; changes in adult smoker behavior; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost and quality of tobacco and other agricultural products and raw materials; and the integrity of its information systems. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to produce and commercialize reduced-risk products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; or if it is unable to attract and retain the best global talent PMI is further subject to other risks detailed from time to time in its publicly filed documents, including the Form 10-Q for the quarter ended September 30, 2017. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations "Reduced-risk products," or "RRPs," is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking A glossary of terms is available at the end of today s webcast slides 2

2017: Key Messages Expect currency-neutral net revenue growth of over 7%: - Partly driven by IQOS device sales, which are currently margin dilutive and increasingly reflect multiple device ownership Anticipate total PMI volume decline of around 3% Sequential momentum in total international market share Continued strong IQOS performance, led by Japan and Korea: - Higher investment currently required to grow IQOS awareness levels outside Asia Net pricing a challenge in Russia, though industry prices beginning to move up slowly Cigarette industry volume in Saudi Arabia / GCC expected to remain under pressure into H1, 2018 Recent industry price increases in the Philippines Not discussing 2018 guidance today. Will provide on February 8, 2018 (Q4 / FY 2017 results) Note: Total PMI volume and total international market share include cigarettes and heated tobacco units. GCC stands for to the Gulf Cooperation Council and includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates Source: PMI Financials or estimates 3

Two Straight Quarters of Strong Sequential Market Share Growth 28.3 0.2 28.0 0.3 PMI International Market Share (%) +0.6pp 27.5 +0.9pp 28.4 0.9 Heated Tobacco Units 28.1 27.7 26.9 0.5 0.7 27.5 Cigarettes 26.4 26.8 Q3 Q4 Q1 Q2 Q3 2016 2017 Note: Excluding China and the U.S. Source: PMI Financials or estimates 4

IQOS: Growing Heated Tobacco Unit National Market Shares Japan Korea Greece Italy Portugal Romania Switzerland 3.5 11.9 13.3 4.5 National SoM (%) 2.5 1.4 2.5 0.1 0.7 0.9 Q3 Q3 Oct Q3 Q3 Oct Q3 Q3 Oct Q3 Q3 Oct Q3 Q3 Oct Q3 Q3 Oct Q3 Q3 Oct 2016 2017 2016 2017 2016 2017 2016 2017 2016 2017 2016 2017 2016 2017 0.1 0.8 1.6 0.1 0.8 1.4 0.4 1.0 1.1 Approximate Weighted Distribution National 63% 75% 73% 36% 48% 59% Coverage (a) (a) Portion of the national cigarette distribution coverage in which heated tobacco products are also sold (as of October 2017) Source: PMI Financials or estimates 5

IQOS: Growing Heated Tobacco Unit Offtake Shares Germany Spain Russia Ukraine Colombia 1.7 1.9 Focus Area Offtake SoM (%) 0.1 Q3 2016 0.6 0.7 0.2 0.3 0.8 0.2 1.3 0.1 Q3 Oct Q3 Q3 Oct Q3 Q3 Oct Q3 Q3 Oct Q3 Q3 Oct 2017 2016 2017 2016 2017 2016 2017 2016 2017 1.2 1.4 Focus Area (October 2017) 7 cities Barcelona & Madrid Moscow 5 cities Bogota Focus Area Cigarette Industry Volume 12% 24% 7% 22% 10% Coverage (a) (a) Portion of cigarette industry volume covered by IQOS focus area in each market (as of October 2017) Source: PMI Financials or estimates 6

Designing a Smoke-Free Future Have you downloaded the PMI Investor Relations App yet? The free IR App is available to download at the Apple App Store for ios devices and at Google Play for Android mobile devices ios Download Android Download Morgan Stanley Global Consumer & Retail Conference Questions & Answers Or go to: www.pmi.com/irapp

Designing a Smoke-Free Future Glossary

Glossary Trademarks are italicized Comparisons are made to the same prior-year period, unless otherwise stated Unless otherwise stated, references to total industry, total market, PMI volume and PMI market share performance reflect cigarettes and PMI s heated tobacco units for those markets that have commercial sales of IQOS References to total international market, defined as worldwide cigarette and PMI heated tobacco unit volume excluding the United States, total industry, total market and market shares are PMI tax-paid estimates based on the latest available data from a number of internal and external sources and may, in defined instances, exclude the People's Republic of China and/or PMI's duty free business "Total PMI volume" is defined as the combined total of cigarette shipment volume and heated tobacco unit shipment volume Net revenues exclude excise taxes "Reduced-risk products," or "RRPs," is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Because PMI's RRPs do not burn tobacco, they produce far lower quantities of harmful and potentially harmful compounds than found in cigarette smoke "IQOS" is the brand name under which PMI has chosen to commercialize its Platform 1 controlled heating device into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol "Heated tobacco units" is the term PMI uses to refer to heated tobacco consumables, which include HEETS, HEETS Marlboro and HEETS FROM MARLBORO, defined collectively as HEETS, as well as Marlboro HeatSticks and Parliament HeatSticks Heated tobacco unit "offtake volume" represents the estimated retail offtake of heated tobacco units based on a selection of sales channels that vary by market, but notably include retail points of sale and e-commerce platforms Heated tobacco unit "offtake share" represents the estimated retail offtake volume of heated tobacco units divided by the sum of estimated total offtake volume for cigarettes, heated tobacco units and, where the data is available, other RRPs "SoM" stands for share of market

Designing a Smoke-Free Future Morgan Stanley Global Consumer & Retail Conference New York, November 14, 2017